AAAAAA

   
Results: 1-10 |
Results: 10
CABERGOLINE TREATMENT RAPIDLY IMPROVES GONADAL-FUNCTION IN HYPERPROLACTINEMIC MALES - A COMPARISON WITH BROMOCRIPTINE
Authors: DEROSA M COLAO A DISARNO A FERONE D LANDI ML ZARILLI S PAESANO L MEROLA B LOMBARDI G
Citation: M. Derosa et al., CABERGOLINE TREATMENT RAPIDLY IMPROVES GONADAL-FUNCTION IN HYPERPROLACTINEMIC MALES - A COMPARISON WITH BROMOCRIPTINE, European journal of endocrinology, 138(3), 1998, pp. 286-293
PROLACTINOMAS IN CHILDREN AND ADOLESCENTS - CLINICAL PRESENTATION ANDLONG-TERM FOLLOW-UP
Authors: COLAO A LOCHE S CAPPA M DISARNO A LANDI ML SARNACCHIARO F FACCIOLLI G LOMBARDI G
Citation: A. Colao et al., PROLACTINOMAS IN CHILDREN AND ADOLESCENTS - CLINICAL PRESENTATION ANDLONG-TERM FOLLOW-UP, The Journal of clinical endocrinology and metabolism, 83(8), 1998, pp. 2777-2780
BONE MARKER AND BONE-DENSITY RESPONSES TO DOPAMINE AGONIST THERAPY INHYPERPROLACTINEMIC MALES
Authors: DISOMMA C COLAO A DISARNO A KLAIN M LANDI ML FACCIOLLI G PIVONELLO R PANZA N SALVATORE M LOMBARDI G
Citation: C. Disomma et al., BONE MARKER AND BONE-DENSITY RESPONSES TO DOPAMINE AGONIST THERAPY INHYPERPROLACTINEMIC MALES, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 807-813
DIFFERENT SENSITIVITY TO SODIUM VALPROATE IN HEALTHY, NONTUMORAL AND TUMORAL HYPERPROLACTINEMIC SUBJECTS
Authors: SARNACCHIARO F COLAO A MEROLA B DISARNO A LANDI ML DISOMMA C FERONE D TOLINO A LOMBARDI G
Citation: F. Sarnacchiaro et al., DIFFERENT SENSITIVITY TO SODIUM VALPROATE IN HEALTHY, NONTUMORAL AND TUMORAL HYPERPROLACTINEMIC SUBJECTS, Journal of endocrinological investigation, 20(9), 1997, pp. 513-518
LONG-TERM AND LOW-DOSE TREATMENT WITH CABERGOLINE INDUCES MACROPROLACTINOMA SHRINKAGE
Authors: COLAO A DISARNO A LANDI ML CIRILLO S SARNACCHIARO F FACCIOLLI G PIVONELLO R CATALDI M MEROLA B ANNUNZIATO L LOMBARDI G
Citation: A. Colao et al., LONG-TERM AND LOW-DOSE TREATMENT WITH CABERGOLINE INDUCES MACROPROLACTINOMA SHRINKAGE, The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3574-3579
CHRONIC TREATMENT WITH CV-205-502 RESTORES THE GONADAL-FUNCTION IN HYPERPROLACTINEMIC MALES
Authors: COLAO A DEROSA M SARNACCHIARO F DISARNO A LANDI ML IERVOLINO E ZARRILLI S MEROLA B LOMBARDI G
Citation: A. Colao et al., CHRONIC TREATMENT WITH CV-205-502 RESTORES THE GONADAL-FUNCTION IN HYPERPROLACTINEMIC MALES, European journal of endocrinology, 135(5), 1996, pp. 548-552
CARDIOVASCULAR ASPECTS IN ACROMEGALY - EFFECTS OF TREATMENT
Authors: LOMBARDI G COLAO A FERONE D MARZULLO P LANDI ML LONGOBARDI S IERVOLINO E CUOCOLO A FAZIO S MEROLA B SACCA L
Citation: G. Lombardi et al., CARDIOVASCULAR ASPECTS IN ACROMEGALY - EFFECTS OF TREATMENT, Metabolism, clinical and experimental, 45(8), 1996, pp. 57-60
COMPARISON AMONG DIFFERENT DOPAMINE-AGONISTS OF NEW FORMULATION IN THE CLINICAL MANAGEMENT OF MACROPROLACTINOMAS
Authors: COLAO A MEROLA B SARNACCHIARO F DISARNO A LANDI ML MARZULLO P CERBONE G FERONE D LOMBARDI G
Citation: A. Colao et al., COMPARISON AMONG DIFFERENT DOPAMINE-AGONISTS OF NEW FORMULATION IN THE CLINICAL MANAGEMENT OF MACROPROLACTINOMAS, Hormone research, 44(5), 1995, pp. 222-228
POSITIVE RESPONSE TO COMPOUND CV-205-502 IN HYPERPROLACTINEMIC PATIENTS RESISTANT TO OR INTOLERANT OF BROMOCRIPTINE
Authors: MEROLA B SARNACCHIARO F COLAO A DISOMMA C DISARNO A FERONE D SELLERI A LANDI ML SCHETTINI G NAPPI C LOMBARDI G
Citation: B. Merola et al., POSITIVE RESPONSE TO COMPOUND CV-205-502 IN HYPERPROLACTINEMIC PATIENTS RESISTANT TO OR INTOLERANT OF BROMOCRIPTINE, Gynecological endocrinology, 8(3), 1994, pp. 175-181
CV-205-502 IN THE TREATMENT OF TUMORAL AND NONTUMORAL HYPERPROLACTINEMIC STATES
Authors: MEROLA B SARNACCHIARO F COLAO A DISOMMA C DISARNO A LANDI ML MARZULLO P PANZA N BATTISTA C LOMBARDI G
Citation: B. Merola et al., CV-205-502 IN THE TREATMENT OF TUMORAL AND NONTUMORAL HYPERPROLACTINEMIC STATES, Biomedicine & pharmacotherapy, 48(3-4), 1994, pp. 167-174
Risultati: 1-10 |